Genetic Editing of Ca Cycling in Diabetic Cardiomyopathy
糖尿病心肌病钙循环的基因编辑
基本信息
- 批准号:7261433
- 负责人:
- 金额:$ 42.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-05-15 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAddressAdultAffectAnimal ModelCa(2+)-Transporting ATPaseCalciumCardiacCardiac MyocytesConsumptionCouplingDefectDiabetes MellitusFunctional disorderGene ExpressionGene TransferGeneticGoalsHeartHeart failureHumanHypertrophyIn VitroInsulinInterventionLeftLinkMechanicsMediatingMetabolicMetabolismMolecularMolecular ProfilingMuscle CellsMyocardialNumbersPathway interactionsPatternPerformancePhosphatidylinositolsPhosphoinositide-3-Kinase, Catalytic, Gamma PolypeptideProtein OverexpressionProteinsRattusRelaxationResearchResearch PersonnelRoleSERCA2aSLC2A1 geneSarcoplasmic ReticulumSignal PathwaySignal Transduction PathwaySignaling MoleculeTestingVentricularViral VectorWorkdiabeticdiabetic cardiomyopathydiabetic ratglucose metabolismglucose uptakeheart preservationimprovedin vivoinsulin signalingmutantphospholambanpreventprogramsrestorationtype I and type II diabetesuptake
项目摘要
DESCRIPTION (provided by applicant): Diabetes impairs left ventricular systolic and diastolic function and is associated with a number of abnormalities at the cellular level in the various steps of excitation-contraction coupling and signaling pathways. Two key abnormalities in experimental diabetic cardiomyopathy are a defect in sarcoplasmic reticulum (SR) function, which is associated with abnormal intracellular calcium handling, and a reduction in phosphatidyl-inositol 3-OH (PI3-) kinase activity and GLUT-4 expression. Deficient SR Ca2+ uptake during relaxation has been identified in diabetic hearts and has been associated with a decrease in the expression and activity of SR Ca2+-ATPase (SERCA2a). Furthermore, a decrease in PI3 kinase activity leading to a decrease in Akt activation and subsequently a decrease in GLUT-4 expression leads to impaired glucose uptake and hypertrophy. Using gene transfer to target specific pathways in cardio-myocytes, we will try to understand whether the excitation-contraction coupling changes in diabetic hearts occur before overt heart failure develops and/or participate in the initiation or the worsening of the changes. We will test the following hypotheses: 1) that the decrease in PI3-Kinase activity is linked to the EC coupling pathways and so contributes to the contractile dysfunction in diabetic hearts: 2) that metabolic interventions will protect against cardiac contractile dysfunction in diabetic hearts: and 3) that modulation of insulin-mediated signal transduction pathways in vivo can favorably modulate alterations of the EC coupling pathways and improve cardiac energetics and survival in diabetic rats. To test these hypotheses, we will use viral vectors to express wild-type and mutant forms of specific signaling molecules in cardiomyocytes in vitro and in vivo. We will examine the effects of PI3-Kinase, Akt, and GLUT-4 on contractile function, energetics and survival and remodeling in diabetic cardiomyopathic hearts. Animal models of type 1 and type 2 diabetes will be utilized in addition to primary cultures of human and adult rats ventricular myocytes.
描述(由申请人提供):糖尿病会损害左心室收缩和舒张功能,并在激发触发偶联和信号通路的各个步骤中与细胞水平的许多异常有关。实验性糖尿病心肌病的两个关键异常是肌质网(SR)功能的缺陷,与异常的细胞内钙处理有关,磷脂酰肌醇3-OH(PI3-)激酶活性和Glut-4表达的降低。在糖尿病心脏中发现了在松弛过程中的SR Ca2+摄取不足,并且与SR Ca2+ -ATPase(SERCA2A)的表达和活性降低有关。此外,PI3激酶活性的降低导致AKT激活降低并随后降低GLUT-4表达会导致葡萄糖摄取和肥大受损。使用基因转移来靶向心肌细胞中的特定途径,我们将尝试了解糖尿病心脏的激发耦合变化是否发生在明显的心力衰竭发展和/或参与变化的启动或加剧之前。我们将测试以下假设:1)PI3-激酶活性的降低与EC耦合途径有关,因此有助于糖尿病心脏的收缩功能障碍:2)代谢干预将在糖尿病心脏中预防糖尿病的心脏疾病中的糖尿病性转变,并在糖尿病上的转变中脱离了胰岛素介导的途径:和3)胰岛素介导的媒介pation in viv in viv in viv in viv in viv in viv in viv in viv in viv ins in viv ins in viv ins in viv ins in viv ins to ins consection in and contrice hearts in and Insight consection。耦合途径并改善糖尿病大鼠的心脏能量和生存。为了检验这些假设,我们将使用病毒载体在体外和体内表达特定信号分子的野生型和突变形式的特定信号分子。我们将研究PI3-激酶,AKT和GLUT-4对糖尿病心肌病心脏中收缩功能,能量和生存以及重塑的影响。除人类和成年大鼠心室心肌细胞的原发性培养外,还将利用1型和2型糖尿病的动物模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roger J. Hajjar其他文献
Therapeutic Targeted Delivery of AAV9 Sh BNIP3 Reverses Cardiac Remodeling and Improves Diastolic and Systolic Function in a Rat Model of Pressure Overload Induced Heart Failure
- DOI:
10.1016/j.cardfail.2012.06.106 - 发表时间:
2012-08-01 - 期刊:
- 影响因子:
- 作者:
Antoine H. Chaanine;Ronald E. Gordon;Ludovic Benard;Erik Kohlbrenner;Roger J. Hajjar - 通讯作者:
Roger J. Hajjar
Spectroscopic Design of Phospholamban Mutants to Treat Heart Failure
- DOI:
10.1016/j.bpj.2009.12.1337 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:
- 作者:
Simon J. Gruber;Suzanne Haydon;Kim N. Ha;Roger J. Hajjar;Gianluigi Veglia;David D. Thomas - 通讯作者:
David D. Thomas
Structure-Based Design of Phospholamban Mutants for Gene Therapy
- DOI:
10.1016/j.bpj.2009.12.4188 - 发表时间:
2010-01-01 - 期刊:
- 影响因子:
- 作者:
Simon J. Gruber;Kim N. Ha;Elizabeth L. Lockamy;Razvan L. Cornea;Roger J. Hajjar;Gianluigi Veglia;David D. Thomas - 通讯作者:
David D. Thomas
1042. Tracking and Gene Expression Profile of Bone Marrow Mesenchymal Stem Cells Injected into Pig Myocardium by Magnetic Resonance Imaging and Laser-Capture Microdissection
- DOI:
10.1016/j.ymthe.2006.08.1138 - 发表时间:
2006-01-01 - 期刊:
- 影响因子:
- 作者:
Elie R. Chemaly;Irina Pomerantseva;Ryuichi Yoneyama;Djamel Lebeche;Davide Gianni;Kozo Hoshino;Yoshiaki Kawase;Federica del Monte;Roger J. Hajjar - 通讯作者:
Roger J. Hajjar
230. In Vivo Fluorescence Tracking System for Cardiac Stem Cell Therapy
- DOI:
10.1016/j.ymthe.2006.08.256 - 发表时间:
2006-01-01 - 期刊:
- 影响因子:
- 作者:
Kozo Hoshino;Hung Q. Ly;Irina Pomerantseva;Yoshiaki Takewa;Ryuichi Yoneyama;Yoshiaki Kawase;Alec M. DeGrande;John V. Frangioni;Roger J. Hajjar - 通讯作者:
Roger J. Hajjar
Roger J. Hajjar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roger J. Hajjar', 18)}}的其他基金
Small Molecule Therapy for the Treatment of Heart Failure
治疗心力衰竭的小分子疗法
- 批准号:
9335758 - 财政年份:2017
- 资助金额:
$ 42.38万 - 项目类别:
Anti-AAV Antibodies as an Obstacle to Cardiac AAV Gene Therapy
抗 AAV 抗体是心脏 AAV 基因治疗的障碍
- 批准号:
9281067 - 财政年份:2016
- 资助金额:
$ 42.38万 - 项目类别:
Anti-AAV Antibodies as an Obstacle to Cardiac AAV Gene Therapy
抗 AAV 抗体是心脏 AAV 基因治疗的障碍
- 批准号:
9176405 - 财政年份:2016
- 资助金额:
$ 42.38万 - 项目类别:
Treating Ventricle and Valve: New Synergies for Ischemic LV Remodeling with MR
治疗心室和瓣膜:MR 缺血性左室重塑的新协同作用
- 批准号:
9195751 - 财政年份:2015
- 资助金额:
$ 42.38万 - 项目类别:
Calcium Pump Activators for Heart Failure Therapy
用于心力衰竭治疗的钙泵激活剂
- 批准号:
9268662 - 财政年份:2015
- 资助金额:
$ 42.38万 - 项目类别:
Calcium Pump Activators for Heart Failure Therapy
用于心力衰竭治疗的钙泵激活剂
- 批准号:
9096874 - 财政年份:2015
- 资助金额:
$ 42.38万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating Resistance Mechanisms to Non-covalent Bruton's Tyrosine Kinase Inhibitors and Therapeutic Approaches to Overcome Resistance for Patients with B-Cell Malignancies
研究非共价布鲁顿酪氨酸激酶抑制剂的耐药机制以及克服 B 细胞恶性肿瘤患者耐药性的治疗方法
- 批准号:
10537252 - 财政年份:2022
- 资助金额:
$ 42.38万 - 项目类别:
The role of kidney epithelial cells specific EP4 receptors in blood pressure control
肾上皮细胞特异性EP4受体在血压控制中的作用
- 批准号:
10586944 - 财政年份:2022
- 资助金额:
$ 42.38万 - 项目类别:
Novel use of PI3K inhibition to prevent recurrence of B-cell acute lymphoblastic leukemia
PI3K 抑制预防 B 细胞急性淋巴细胞白血病复发的新用途
- 批准号:
10455633 - 财政年份:2021
- 资助金额:
$ 42.38万 - 项目类别:
Outer Membrane Proteins of Pathogenic Oral Treponemes Inhibit Actin Rearrangement and Antimicrobial Functions of Neutrophils
致病性口腔密螺旋体外膜蛋白抑制中性粒细胞肌动蛋白重排和抗菌功能
- 批准号:
10491690 - 财政年份:2021
- 资助金额:
$ 42.38万 - 项目类别:
Ac-SDKP in the Treatment of Cardiac Dysfunction in Hypertension or Ischemic
Ac-SDKP 治疗高血压或缺血性心脏功能障碍
- 批准号:
10336561 - 财政年份:2021
- 资助金额:
$ 42.38万 - 项目类别: